LT1390070T - Il-18 inhibitoriaus panaudojimas cns pažeidimų gydymui arba prevencijai - Google Patents
Il-18 inhibitoriaus panaudojimas cns pažeidimų gydymui arba prevencijaiInfo
- Publication number
- LT1390070T LT1390070T LTEP02740641.2T LT02740641T LT1390070T LT 1390070 T LT1390070 T LT 1390070T LT 02740641 T LT02740641 T LT 02740641T LT 1390070 T LT1390070 T LT 1390070T
- Authority
- LT
- Lithuania
- Prior art keywords
- inhibitors
- treating
- cns injuries
- preventing cns
- preventing
- Prior art date
Links
- 230000006378 damage Effects 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01112067 | 2001-05-25 | ||
| PCT/EP2002/005666 WO2002096456A1 (en) | 2001-05-25 | 2002-05-23 | Use of il-18 inhibitors for treating or preventing cns injuries |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LT1390070T true LT1390070T (lt) | 2017-03-10 |
Family
ID=8177454
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTEP02740641.2T LT1390070T (lt) | 2001-05-25 | 2002-05-23 | Il-18 inhibitoriaus panaudojimas cns pažeidimų gydymui arba prevencijai |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US7655616B2 (lt) |
| EP (1) | EP1390070B1 (lt) |
| JP (1) | JP4344142B2 (lt) |
| KR (1) | KR20040030625A (lt) |
| CN (1) | CN1305529C (lt) |
| AU (1) | AU2002314103B2 (lt) |
| BG (1) | BG66395B1 (lt) |
| BR (1) | BR0210007A (lt) |
| CA (1) | CA2445664C (lt) |
| CY (1) | CY1119190T1 (lt) |
| CZ (1) | CZ307321B6 (lt) |
| DK (1) | DK1390070T3 (lt) |
| EA (1) | EA006744B1 (lt) |
| EE (1) | EE05263B1 (lt) |
| ES (1) | ES2617084T3 (lt) |
| HR (1) | HRP20030842B1 (lt) |
| HU (1) | HU230294B1 (lt) |
| IL (2) | IL159014A0 (lt) |
| LT (1) | LT1390070T (lt) |
| ME (1) | ME00550B (lt) |
| MX (1) | MXPA03010743A (lt) |
| NO (1) | NO331882B1 (lt) |
| PL (1) | PL216228B1 (lt) |
| PT (1) | PT1390070T (lt) |
| RS (1) | RS56006B1 (lt) |
| SK (1) | SK288413B6 (lt) |
| UA (1) | UA80396C2 (lt) |
| WO (1) | WO2002096456A1 (lt) |
| ZA (1) | ZA200308172B (lt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080076708A1 (en) | 2003-05-13 | 2008-03-27 | Valter Altarocca | Active Variants of the Il-18 Binding Protein and Medical Uses Thereof |
| EP1780542A4 (en) * | 2004-06-30 | 2008-05-14 | Atsuo Sekiyama | AGENT INDICATING A NON-INFLAMMATORY RESPONSE TO A STRESS AND USE THEREOF |
| SI1888100T1 (sl) * | 2005-06-03 | 2012-01-31 | Merck Serono Sa | Uporaba izooblik il-18pb za zdravljenje in/ali prepreäśevanje nevroloĺ kih vnetnih bolezni |
| PL1885753T3 (pl) | 2005-06-03 | 2011-12-30 | Ares Trading Sa | Wytwarzanie rekombinowanego białka wiążącego IL-18 |
| ATE529433T1 (de) | 2005-06-10 | 2011-11-15 | Ares Trading Sa | Verfahren zur reinigung eines il-18-bindenden proteins |
| US8685400B2 (en) * | 2007-07-30 | 2014-04-01 | University Of Miami | Modulating inflammasome activity and inflammation in the central nervous system |
| KR102321172B1 (ko) * | 2013-09-05 | 2021-11-05 | 에이비2 바이오 에스에이 | 염증성 질환에서 il-18 결합 단백질(il-18bp) |
| CA2972689A1 (en) * | 2015-03-05 | 2016-09-09 | Ab2 Bio Sa | Il-18 binding protein (il-18bp) and antibodies in inflammatory diseases |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0873453A (ja) * | 1994-09-02 | 1996-03-19 | Otsuka Pharmaceut Co Ltd | サイトカイン阻害剤 |
| IL121860A0 (en) * | 1997-08-14 | 1998-02-22 | Yeda Res & Dev | Interleukin-18 binding proteins their preparation and use |
| ES2244178T3 (es) * | 1998-03-09 | 2005-12-01 | Vertex Pharmaceuticals Incorporated | Derivados de 1,2-diazepan como inhibidores de la enzima convertidora de interleuquina-1 beta. |
| CA2276216A1 (en) * | 1998-06-24 | 1999-12-24 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | An artificial peptide capable of neutralizing the biological activity of interleukin-18 |
| EA007014B1 (ru) * | 2000-05-05 | 2006-06-30 | Апплайд Резеч Системз Арс Холдинг Н.В. | Применение il-18 в качестве диагностического маркера |
| AU2001266289A1 (en) * | 2000-06-23 | 2002-01-02 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | 2-arachidonylglycerol (2-ag) - an inhibitor of tumor necrosis factor -alfa and neuroprotector of brain in closed head injury |
| AU2002224417A1 (en) * | 2000-10-18 | 2002-04-29 | Immunex Corporation | Methods for treating il-18 mediated disorders |
| US6671553B1 (en) * | 2001-05-23 | 2003-12-30 | Pacesetter, Inc. | Implantable cardiac lead having terminating connector strain relief and method of manufacture |
-
2002
- 2002-05-23 IL IL15901402A patent/IL159014A0/xx unknown
- 2002-05-23 RS YU89403A patent/RS56006B1/sr unknown
- 2002-05-23 MX MXPA03010743A patent/MXPA03010743A/es active IP Right Grant
- 2002-05-23 HU HU0304067A patent/HU230294B1/hu unknown
- 2002-05-23 ME MEP-2008-618A patent/ME00550B/me unknown
- 2002-05-23 AU AU2002314103A patent/AU2002314103B2/en not_active Expired
- 2002-05-23 LT LTEP02740641.2T patent/LT1390070T/lt unknown
- 2002-05-23 UA UA20031212328A patent/UA80396C2/uk unknown
- 2002-05-23 PT PT2740641T patent/PT1390070T/pt unknown
- 2002-05-23 CZ CZ2003-3268A patent/CZ307321B6/cs not_active IP Right Cessation
- 2002-05-23 WO PCT/EP2002/005666 patent/WO2002096456A1/en not_active Ceased
- 2002-05-23 CN CNB028147510A patent/CN1305529C/zh not_active Expired - Lifetime
- 2002-05-23 BR BR0210007-0A patent/BR0210007A/pt not_active Application Discontinuation
- 2002-05-23 KR KR10-2003-7015310A patent/KR20040030625A/ko not_active Ceased
- 2002-05-23 PL PL367545A patent/PL216228B1/pl unknown
- 2002-05-23 JP JP2002592965A patent/JP4344142B2/ja not_active Expired - Lifetime
- 2002-05-23 EE EEP200300582A patent/EE05263B1/xx unknown
- 2002-05-23 DK DK02740641.2T patent/DK1390070T3/en active
- 2002-05-23 HR HRP20030842AA patent/HRP20030842B1/hr not_active IP Right Cessation
- 2002-05-23 EA EA200301299A patent/EA006744B1/ru not_active IP Right Cessation
- 2002-05-23 US US10/478,614 patent/US7655616B2/en not_active Expired - Lifetime
- 2002-05-23 ES ES02740641.2T patent/ES2617084T3/es not_active Expired - Lifetime
- 2002-05-23 CA CA2445664A patent/CA2445664C/en not_active Expired - Lifetime
- 2002-05-23 SK SK1603-2003A patent/SK288413B6/sk not_active IP Right Cessation
- 2002-05-23 EP EP02740641.2A patent/EP1390070B1/en not_active Expired - Lifetime
-
2003
- 2003-10-21 ZA ZA200308172A patent/ZA200308172B/xx unknown
- 2003-11-20 NO NO20035160A patent/NO331882B1/no not_active IP Right Cessation
- 2003-11-23 IL IL159014A patent/IL159014A/en active IP Right Grant
- 2003-12-15 BG BG108451A patent/BG66395B1/bg unknown
-
2017
- 2017-05-08 CY CY20171100494T patent/CY1119190T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL157656A0 (en) | Metalloproteinase inhibitors | |
| IL157570A0 (en) | Metalloproteinase inhibitors | |
| HUP0302719A3 (en) | Substituted amine derivatives and their use for the treatment of angiogenesis | |
| HUP0402075A3 (en) | Compositions for treatment of common cold | |
| ZA200208228B (en) | Use of il-18 inhibitors for the treatment and/or prevention of athesclerosis | |
| HUP0300061A3 (en) | Use of il-18 inhibitors | |
| IL157658A0 (en) | Metalloproteinase inhibitors | |
| EP1337255A4 (en) | USE OF P38 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY COUGH | |
| IL161059A0 (en) | Substituted benzimidazole compounds and their use for the treatment of cancer | |
| IL153971A0 (en) | Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity | |
| HRP20030842A2 (en) | Use of il-18 inhibitors for treating or preventing cns injuries | |
| IL131047A0 (en) | Use of il-18 inhibitors | |
| IL157588A0 (en) | Carbamate compounds for use in preventing or treating psychotic disorders | |
| HUP0302430A3 (en) | Use of 1-phenyl-3-dimethylaminopropane compounds for treating urinary incontience | |
| IL160230A0 (en) | Use of il-18 inhibitors | |
| SI1458703T1 (sl) | Izokromanske spojine za zdravljenje motenj centralnega živčnega sistema | |
| EP1450849A4 (en) | METHOD FOR TREATING ENDOMETREOSE | |
| GB0119460D0 (en) | The use of inhibitors of the renin-angiotensin system | |
| AU2002360614A8 (en) | Methods of inhibiting fertility | |
| GB0129388D0 (en) | Use of compounds for treating cancer | |
| SI1307262T1 (en) | Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity | |
| GB0100646D0 (en) | Compositions for therapy and prophylaxis | |
| AU2003301170A8 (en) | Compositions for the treatment and prevention of nephropathy | |
| SI1569929T1 (sl) | Spojine in postopki za zdravljenje ali preprečevanje flavivirusnih infekcij |